Mayne Pharma Group Ltd (ASX:MYX)
A$ 4.58 -0.05 (-1.08%) Market Cap: 389.64 Mil Enterprise Value: 279.18 Mil PE Ratio: 0 PB Ratio: 0.83 GF Score: 75/100

Half Year 2019 Mayne Pharma Group Ltd Earnings Presentation Transcript

Feb 21, 2019 / 11:00PM GMT
Release Date Price: A$16 (-1.23%)

Feb 21, 2019 / 11:00PM GMT
Presentation
Feb 21, 2019 / 11:00PM GMT

=====================
Corporate Participants
=====================
* Brant Schofield
Mayne Pharma Group Limited - EVP of Specialty Brands
* Nick Freeman
Mayne Pharma Group Limited - Group CFO & Company Secretary
* Scott Anthony Richards
Mayne Pharma Group Limited - MD, CEO & Executive Director

=====================
Conference Call Participants
=====================
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* John Hester
Bell Potter Securities Limited, Research Division - Senior Healthcare Equities Analyst
* Michael Gerges
Blue Ocean Equities Pty Ltd, Research Division - Investment Analyst
* Saul Hadassin
UBS Investment Bank, Research Division - Executive Director & Research Analyst
* Simon

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot